Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - EU Market Recap: FTSE 100 +0.06% to 8786.46, DAX +0.36% to 24122.40, CAC40 (0.40%) to 7910.49, STOXX 600 (0.04%) to 553.82

May 21 ,2025

  • Synopsis:

    • European indices ended mostly mixed. Germany outperforms. Telco and tech the best performers whilst retail, autos and travel/leisure biggest laggards. Follows positive performance Monday and Tuesday with Dax at fresh all-time highs. Market sentiment remain mixed.

    • Focus remain on trade with the European Union preparing a revised proposal aimed at reviving stalled negotiations with the Trump administration, Bloomberg reports. Sources said the new paper addresses US interests by proposing tariff reductions on non-sensitive agricultural and industrial goods, and cooperation in areas like labor rights, environmental standards, digital trade and economic security.

    • In macro data, UK inflation surged unexpectedly to 3.5% in Apr, marking highest level in over a year and exceeding both BoE forecasts (3.4%) and economist expectations (3.3%). This sharp increase from Mar's 2.6% driven by barrage of price hikes across essential services, notably a 6.4% rise in energy price cap, alongside increases in water bills, train fares, and local taxes. Services inflation accelerated significantly to 5.4% from 4.7%, also exceeding central bank projections. Inflation spike coincided with major policy changes, including a £26B increase in employer payroll taxes and ~7% rise in minimum wage. While BoE views this as a temporary phenomenon that will peak at 3.7% in Sept, it presents a fresh economic challenge for PM Starmer's government, particularly with households experiencing renewed cost-of-living pressures amid concerns about potential impacts from Trump's tariffs. Data also justifies Chief Economist Pill's comments on Tuesday that rate cuts were progressing too quickly. Traders pared BoE easing bets on the data, with just 25bps of easing seen by Dec-2025.

    • Light on the corporate front. Marks & Spencer (MKS.LN) FY results beat estimates but cyberattack cost company over £60M and may create 10-15% risk to FY26 earnings consensus. Out of DACHs, Ypsomed Holding (YPSN.SW) FY earnings missed, SoftwareONE Holding (SWON.SW) Q1 revenue dropped, adjusted EBITDA rose, whilst Idorsia (IDIA.SW) upgraded its guidance for 2025 following the successful commercial ramp-up of QUVIVIQ. Also, Julius Baer (BAER.SW) reported mixed 4M IMS with AuM but with a focus on an unexpected CHF 130M loan loss charge. Of note, Infineon (IFX.GR) to work with Nvidia on power delivery chips. Elsewhere, passenger traffic at Vinci (DG.FP) Airports showed marked acceleration in April.

    • Looking ahead to tomorrow's EU econ-calendar, notable releases will include, amongst others, Eurozone, France, Germany, UK May preliminary manufacturing/services PMIs, Germany May IFO survey, France May business climate/survey and UK May industrial trends orders - CBI.

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers:

        • Telecom +0.89%, Technology +0.65%, Food & Beverage +0.33%, Health Care +0.27%, Insurance +0.25%, Utilities +0.06%

      • Underperformers:

        • Retail (0.74%), Autos & Parts (0.72%), Travel & Leisure (0.72%), Oil & Gas (0.63%), Construct & Mtls (0.62%), Persnl & HHold Goods (0.58%), Real Estate (0.49%), Financial Svcs (0.41%), Chemicals (0.36%), Media (0.20%), Ind Goods & Svcs (0.13%), Basic Resources (0.15%), Banks (0.08%)

    • Macro:

      • Central Banks:

        • ECB's Centeno: rate cuts below neutral level may be needed to keep inflation on target -- Reuters

        • ECB's Guindos Sees Price Target Hit Sooner Rather Than Later -- Bloomberg

      • EU:

        • Commission exempts 38,000 companies from 8 EU laws -- Politico

        • EU prepares trade proposal for US to steer momentum into talks -- Bloomberg

      • UK:

        • Starmer has surrendered to the EU -- Spectator

        • Britain will be negotiating with Europe forever -- FT

        • UK inflation jumps in April, raising prospect of BoE rate cut delay -- Reuters

      • Germany:

        • Almost 40% of Companies Lament Lack of Orders -- Ifo

        • Merz Advisers See Germany in Stagnation But Recovery in Sight -- Bloomberg

      • Italy:

        • Meloni looks to Moody's to finally end Italy's near junk status -- Bloomberg

        • Meloni Secures Senate Backing for Albania Migration Deal -- European Conservatives

    • Company news:

      • Notable Gainers

        • +44.3% ACTI.SS (Active Biotech SEK0.16, +0.05) -- patent for tasquinimod in myelofibrosis granted in Europe

        • +15.3% SHLF.NO (Shelf Drilling NOK6.40, +0.85) -- Undisclosed financial investor engages ABG Sundal Collier to explore potential block purchase of up to ~12.8M shares in Shelf Drilling representing ~5% of the outstanding shares

        • +11.0% BIOA.B.SS (BioArctic SEK203.20, +20.40) -- reports Q1 EPS SEK11.53 vs FactSet SEK10.42 [1 est]

        • +9.2% MRX.GR (Mister Spex €1.54, +0.13) -- CEO acquires 70,000 shares

        • +8.5% AVTX.NA (Avantium €13.60, +1.02) -- capacity reservation agreement with BIOVOX for PEF in pharmaceutical applications

        • +6.7% EPRO.B.SS (Electrolux Professional SEK67.10, +4.20) -- transferred buy at Handelsbanken; prior rating was hold

        • +5.5% PHM.SM (Pharma Mar €88.75, +4.65) -- submits EU MAA for lurbinectedin in combination with atezolizumab in first-line maintenance therapy for ES-SCLC

        • +5.5% YPSN.SW (Ypsomed Holding CHF371.50, +19.50) -- reports FY net income CHF87.5M vs FactSet CHF105.1M [3 est, CHF92.0-124M]; initiates sale of Diabetes Care business

        • +5.3% GNFT.FP (GENFIT €4.04, +0.20) -- to receive €26.5M milestone payment following approval of pricing and reimbursement of Ipsen's Iqirvo in Italy

        • +5.2% AVON.LN (Avon Technologies £16.92, +0.82) -- reports H1 EPS $0.39 vs FactSet $0.30 [1 est]

        • +5.1% LOGI.A.SS (Logistea SEK14.40, +0.70) -- to acquire logistics property Ytteråker 2:5, in Vansbro Sweden; underlying property value of SEK433M

        • +4.8% M12.GR (M1 Kliniken €14.62, +0.68) -- annual report for 2024 financial year confirming preliminary results as of 29-Apr

        • +4.6% IMMNOV.SS (Immunovia SEK0.34, +0.02) -- selected to present its clinical data at the Scientific Workshop Poster Session of EDRN

        • +4.5% CARR.LN (Carr's Group £1.52, +0.06) -- to return up-to-£70M to shareholders via 163p per share tender offer

        • +4.4% IDIA.SW (Idorsia CHF1.48, +0.06) -- upgrades guidance for 2025 due to successful commercial ramp-up of QUVIVIQ

        • +4.1% ZIG.LN (Zigup Plc £3.50, +0.14) -- ZIGUP PLC FY Trading Update: expect to finish the year modestly ahead of market expectations

        • +4.1% ORNBV.FH (Orion €60.05, +2.35) -- MSD to carry out Phase 2 trial of MK-5684 to treat breast cancer, ovarian cancer, endometrial cancer

        • +2.3% SVT.LN (Severn Trent £27.56, +0.62) -- reports FY adj. EPS 112.1p vs FactSet 101.5p [8 est, 98.4-107.9p]

        • +2.0% BOUV.NO (Bouvet NOK79.50, +1.60) -- reports Q1 EPS NOK1.16 vs FactSet NOK1.20 [3 est, NOK1.17-1.22]

        • +1.6% FOUR.LN (4imprint Group £35.10, +0.55) -- AGM Trading Update: The group has delivered a resilient operational and financial performance in the early part of 2025

        • +1.5% STAF.LN (Staffline Group £0.41, +0.01) -- Jan-Apr trading update: reports +6.2% y/y increase in gross profit cont ops

      • Notable Decliners

        • -22.4% PANR.LN (Pantheon Resources £0.20, -0.06) -- Megrez-1 low test now complete: no mobile oil discovered

        • -22.3% IDEX.NO (IDEX Biometrics NOK0.06, -0.02) -- reports Q1 net income (NOK4.1M) vs year-ago (NOK5.4M)

        • -19.6% SHOE.LN (Shoe Zone £0.93, -0.23) -- H1 EPS (4.9p) vs year-ago 5.6p

        • -10.6% JD.LN (JD Sports Fashion £0.85, -0.10) -- reports FY EPS 12.4p vs FactSet 12.1p [17 est, 11.6-12.4p]; Q126 trading in line with expectations

        • -8.4% HBH.GR (Hornbach Holding €96.70, -9.00) -- reports FY EPS €8.80 vs FactSet €9.58 [6 est, €8.82-10.17]; revenues and adj. EBIT in line with prelims; issues guidance 2025/26

        • -6.9% TMO.LN (Time Out Group £0.27, -0.02) -- FY Trading Update: adjusted EBITDA after central costs £11-13M vs FactSet £15.4M [1 est]

        • -5.7% HEIT.LN (Harmony Energy Income Trust £0.92, -0.05) -- Drax Group confirms that it will not be increasing the financial terms of its offer for HEIT; offer expected to lapse on 29-May

        • -5.7% HEIT.LN (Harmony Energy Income Trust £0.92, -0.05) -- UK's Takeover Panel announces cancellation of auction procedure regarding HEIT

        • -5.4% NORSE.NO (Norse Atlantic NOK6.30, -0.35) -- Q1 net income ($14.9M) vs year-ago ($62.8M)

        • -5.3% RS1.LN (RS Group plc £5.82, -0.32) -- reports FY EPS 39.1p ex-items vs FactSet 38.0p [14 est, 35.5-39.1p]

        • -5.0% ISOFOL.SS (Isofol Medical SEK1.22, -0.06) -- reports Q1 EPS (SEK0.08) vs year-ago (SEK0.05)

        • -4.8% PRS.NO (Prosafe NOK8.05, -0.41) -- reports Apr Fleet utilisation of 58%

        • -4.8% PRS.NO (Prosafe NOK8.05, -0.41) -- reports Q1 EPS ($0.83) vs year-ago ($0.48)

        • -4.8% BAER.SW (Julius Baer Group CHF54.68, -2.78) -- 4M trading update: AuM CHF 467B; announces total net charge of CHF 130M; outlook remains uncertain

        • -4.7% CADLR.NO (Cadeler NOK49.90, -2.42) -- reports Q1 EBITDA €24.0M vs FactSet €37.5M [8 est, €20-53M]; confirms FY25 outlook

        • -4.5% GOGL.NO (Golden Ocean Group NOK76.65, -3.65) -- reports Q1 EPS ($0.22) vs FactSet ($0.17) [8 est, ($0.22)-(0.09)]

        • -3.6% CMBT.BB (CMB.TECH €8.30, -0.31) -- reports Q1 net income $44.0M vs FactSet $38.3M [4 est, $23.7-51M]

        • -3.5% CBG.LN (Close Brothers Group £3.55, -0.13) -- reports Q3 net interest margin 7.1% vs H1 25 7.3%; expect FY net interest margin to be ~7%

        • -3.5% NETEL.SS (Netel Holding SEK9.57, -0.36) -- Holder Cinnamon International completes sale of ~22.6M shares (~46.7%) in Netel Holding AB

        • -3.3% PPC.GA (Public Power Corp. €13.31, -0.46) -- on track to achieve its 2027 RES target with minimized execution risk - slides

        • -2.8% PTEC.LN (Playtech £3.43, -0.10) -- trading update: 4M trading in line with expectations

        • -2.5% KER.FP (Kering €180.04, -4.64) -- Kering Eyewear partners with Google (GOOGL) to develop AI-powered glasses with Android XR

        • -2.4% SSE.LN (Scottish and Southern Energy £17.64, -0.43) -- reports FY EPS 160.9p ex-items vs FactSet 158.5p [14 est, 155.5-164.1p]

        • -2.4% COA.LN (Coats Group £0.77, -0.02) -- Jan-Apr trading update: group revenue (constant exchange rate) increased by +4% y/y

        • -2.3% CRAYN.NO (Crayon Group Holding NOK135.80, -3.10) -- reports Q1 EPS NOK0.54 vs FactSet NOK1.12 [4 est, NOK0.90-1.29]

        • -2.3% IHP.LN (Integrafin Holdings £3.13, -0.07) -- reports H1 underlying EPS 8.8p vs FactSet 8.5p [3 est, 8.0-9.3p]

        • -2.2% TNXT.IM (Tinexta €11.66, -0.26) -- closes the acquisition of 25% stake in ABF Group (post EU close 20-May)

    • EU companies reporting tomorrow:

      • Earnings:

        • Benelux: Gimv (GIMB.BB)

        • DACHs: CTS Eventim (EVD.GR), Datagroup (D6H.GR), Allane (LNSX.GR), NFON (NFN.GR), PORR (POS.AV), BKS Bank (BKS.AV), Schoeller-Bleckmann Oilfield Equipment (SBO.AV)

        • Nordics: Embracer Group (EMBRAC.B.SS), Done.ai Group (DONE.SS), Grieg Seafood (GSF.NO), Måsøval (MAS.NO), SP Group (SPG.DC), PARKEN Sport & Entertainment (PARKEN.DC)

        • Southern Europe: Assicurazioni Generali (G.IM), Multitude (FRU.MIL.IM)

        • UK: BT Group (BT.A.LN), EasyJet (EZJ.LN), British Land Co. (BLND.LN), Investec (INVP.LN), Tate & Lyle (TATE.LN), QinetiQ Group (QQ.LN), Atalaya Mining (ATYM.LN), Impax Asset Management Group (IPX.LN)

      • Trading Update:

        • Benelux: Ion Beam Applications (IBAB.BB)

        • DACHs: Galenica (GALE.SW), STRABAG SE (STR.AV), 2G Energy (2GB.GR)

        • France: GENFIT (GNFT.FP)

        • UK: Intertek Group (ITRK.LN), ConvaTec Group (CTEC.LN), Hill & Smith (HILS.LN), Zotefoams (ZTF.LN)

  • Data:

    • Economics:

      • UK Apr CPI +3.5% y/y vs consensus +3.3% and prior +2.6%

    • Markets:

      • WTI Crude (25-Jul): ($0.22) or (0.35%) to $61.81

      • €-$ +0.0056 or +0.50% to 1.1341

      • £-$ +0.0052 or +0.39% to 1.3445

      • €-£ +0.0011 to 0.8436

      • S&P 500 (0.16%)

      • Performance year-to-date:

        • FTSE 100: +7.51%

        • DAX: +21.16%

        • CAC: +7.18%

        • MIB: +18.62%

        • Stoxx 600: +9.10%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE